1 SUMMARY
We have developed a globally applicable diagnostic Covid-19 model by augmenting the classical SIR epidemiological model with a neural network module. Our model does not rely upon previous epidemics like SARS/MERS and all parameters are optimized via machine learning algorithms employed on publicly available Covid-19 data. The model decomposes the contributions to the infection timeseries to analyze and compare the role of quarantine control policies employed in highly affected regions of Europe, North America, South America and Asia in controlling the spread of the virus. For all continents considered, our results show a generally strong correlation between strengthening of the quarantine controls as learnt by the model and actions taken by the regions’ respective governments. Finally, we have hosted our quarantine diagnosis results for the top 70 affected countries worldwide, on a public platform, which can be used for informed decision making by public health officials and researchers alike.
Article Summary Line Data-driven epidemiological model to quantify and compare quarantine control policies in controlling COVID-19 spread in Europe, North America, South America and Asia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This effort was partially funded by the Intelligence Advanced Reseach Projects Activity (IARPA.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research was in the field of data analysis/machine learning and was conduced with publicly available Covid-19 data; in affiliation with MIT.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data for the infected and recovered case count in all regions was obtained from the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. All code files are available at https://github.com/RajDandekar/MIT-Global-COVID-Modelling-Project-1. All results are publicly hosted at https://covid19ml.org/ or https://rajdandekar.github.io/COVID-QuarantineStrength/.
